The ITHS core group Integrating Special Populations (ISP) has developed a new resource to promote health equity within research that’s done virtually. “Guidelines for Equitable and Effective Teleresearch Engagement” was published in November of 2024, and can be found under the ‘Equity in Research Resources” tab...
The new "Hot New Grants" page on the ITHS website offers an exciting collection of cutting-edge funding opportunities for researchers, entrepreneurs, and innovators. This new online resource highlights the latest grants designed to support translational research, technology commercialization, and collaborative interdisciplinary projects. Visitors will find...
ITHS is pleased to announce the winners of its Translational Science Acceleration Awards. Leaders of the awarded projects will receive pilot funding to support planning and development of approaches that aim to address significant roadblocks in clinical and translational research. Project awardees: Taran Gujral, PhD, Associate...
The ITHS profile series is meant to shine a deserving spotlight on individuals within the institute doing critical work across the vast spectrum of translational science. In our July installment, we are focusing on the vibrant career of Dr. Kari A. Stephens, a longtime faculty...
A promising study published in The New England Journal of Medicine showed that semaglutide, the compound in Ozempic and Wegovy, dramatically reduced the risk of kidney complications, heart issues and death in people with Type 2 diabetes and chronic kidney disease. The findings of this major clinical...
ITHS is thrilled to announce that Clearwater Valley/St. Mary's Health System and Dr. Kelly McGrath, MD, MS, who is the Chief Medical Officer at Clearwater Valley/St. Mary’s Health System and co-Director of the ITHS’ Rural Health Initiative, have been selected as finalists for the NIH...
The 2024 Expo & Symposium was a rousing success this year, attracting over 100 guests on a warm spring afternoon. Held at the Center for Urban Horticulture on the east side of the University of Washington campus, the event created a vibrant atmosphere for attendees...
This year, we began a new profile series to shed light on some of the distinguished scholars currently participating in our KL2 Program. The first installment profiled someone at the very beginning of their KL2 experience, Dr. Blake Langley. Now, we’re speaking to someone who...
The ITHS Pilot program is happy to officially welcome Teddy Johnson as the new co-director of the Pilot Program. He is not new to the team, as he’s been an advisor to the program for several years, specializing in commercial development. Also joining the team...
ITHS, in collaboration with the Andy Hill Cancer Research Endowment CARE Fund, is proud to announce the RADIANT program. This initiative addresses a critical area of need in oncology research: the lack of diversity among participants of cancer clinical trials. Purpose Cancer affects people from all walks...